Jefferies Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $10
Jefferies Releases a Buy Rating on Nuvation Bio (NUVB)
Nuvation Bio Is Maintained at Buy by HC Wainwright & Co.
Nuvation Bio Analyst Ratings
H.C. Wainwright Maintains Nuvation Bio(NUVB.US) With Buy Rating, Cuts Target Price to $7
Wedbush Reiterates Outperform on Nuvation Bio, Maintains $5 Price Target
Wedbush Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $5
Jefferies Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $10
Nuvation Bio Analyst Ratings
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $5
Nuvation Bio (NUVB) Gets a Buy From RBC Capital
TD Cowen Maintains Nuvation Bio(NUVB.US) With Buy Rating
Nuvation Bio Earns Buy Rating on Robust Pipeline and Strategic Focus
BTIG Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $5
Analysts' Top Healthcare Picks: Intuitive Surgical (ISRG), Nuvation Bio (NUVB)
Buy Rating Affirmed for Nuvation Bio Amid Promising Taletrectinib Trials and Orphan Drug Designation
Nuvation Bio Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Nuvation Bio, Maintains $8 Price Target
Nuvation Bio Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Nuvation Bio, Maintains $8 Price Target
No Data
No Data